Obtenga información sobre cómo los expertos en cáncer pulmonar de MSK usan quimioterapia, inmunoterapia y otras terapias sistémicas para tratar el cáncer pulmonar de células pequeñas y de células no ...

Learn about MSK’s Healthy Living, a lifestyle program for people with breast cancer, where diet, nutrition, exercise and integrative medicine come together to improve quality of life.

Experts at MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer are devoted to creating the best treatment plan for you and your family.

When you learn you have lung cancer, you’ll probably have many questions. Talking about treatment options with your doctors can help you feel confident when making decisions about your care ...

Memorial Sloan Kettering Cancer Center (MSK) and Curadev Pharma, Inc., a biotechnology company developing novel immuno-oncology therapeutics, are expanding their collaboration through the MSK ...

The Hite laboratory studies the mechanisms of ion and metabolite transport and the maintenance of genomic integrity.

Full Title A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) /Lymphoplasmacytic Lymphoma ...

I am currently a PhD student working in the labs of Dr. Daniel Heller and Dr. Raphael Lis. Here I am using organoid models to further our understanding of heterogeneity across brain vasculature, and ...

Dr. Samuel Cytryn treats esophageal, stomach and other GI cancers at MSK New York and MSK Westchester, using immunotherapy, targeted therapy and clinical trials.

Dr. Neha Goel is a breast cancer surgeon at MSK specializing in oncoplastic and nipple-sparing surgery, as well as research on how environment impacts outcomes.

Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

Dr. Michael Foote treats gastrointestinal cancers at MSK, including colorectal, pancreatic and rare appendiceal cancers, using personalized, targeted therapies.